BlackRock Health Sciences Trust (NYSE:BME) Stock Crosses Above 50 Day Moving Average – Time to Sell?

BlackRock Health Sciences Trust (NYSE:BME) shares crossed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $41.87 and traded as high as $43.71. BlackRock Health Sciences Trust shares last traded at $43.43, with a volume of 46,927 shares changing hands.

BlackRock Health Sciences Trust Stock Performance

The business’s 50-day moving average price is $42.01 and its 200 day moving average price is $40.93.

BlackRock Health Sciences Trust Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a dividend of $0.2621 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) annualized dividend and a yield of 7.1%.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. boosted its stake in shares of BlackRock Health Sciences Trust by 285,436.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock valued at $166,414,000 after buying an additional 4,044,638 shares during the last quarter. Truist Financial Corp grew its position in shares of BlackRock Health Sciences Trust by 23.7% during the fourth quarter. Truist Financial Corp now owns 6,811 shares of the company’s stock worth $280,000 after buying an additional 1,306 shares in the last quarter. AlphaStar Capital Management LLC increased its stake in shares of BlackRock Health Sciences Trust by 2.2% in the fourth quarter. AlphaStar Capital Management LLC now owns 12,099 shares of the company’s stock worth $498,000 after buying an additional 258 shares during the last quarter. Calamos Advisors LLC increased its stake in shares of BlackRock Health Sciences Trust by 63.8% in the fourth quarter. Calamos Advisors LLC now owns 26,020 shares of the company’s stock worth $1,070,000 after buying an additional 10,135 shares during the last quarter. Finally, Wealthspire Retirement LLC raised its holdings in BlackRock Health Sciences Trust by 12.2% in the first quarter. Wealthspire Retirement LLC now owns 51,887 shares of the company’s stock valued at $1,998,000 after acquiring an additional 5,635 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.